QL Biopharma: Funding, Investors & Team (Sep 2026)
QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.
QL Biopharma has raised $44.7M across 1 funding round on record, the most recent a Series C of $44.7M announced in Sep 2026.
That round is above the $15M median round size for China companies tracked on FundedIQ over the last two years.
QL Biopharma Company Profile and Key Stats
Latest funding round on record: Sep 2026.
QL Biopharma Funding Rounds
QL Biopharma Investors
21 investors are recorded in total; the 5 named above are those the record identifies.
QL Biopharma Founders and Leadership Team
Contact details for the QL Biopharma team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →QL Biopharma Funding in Context
QL Biopharma's latest round of $44.7M is above the median round in China. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like QL Biopharma in Biopharma and Changping
Companies Similar to QL Biopharma
Jinjing Keji manufactures cathode fluorescence system instruments.
Developer of electric outboards, batteries, and control systems for smart and sustainable water mobility.
Hello TransTech (formerly HelloBike) develops smart-sharing bikes for short distance travelers in China.
Chuangcai Advanced Education is a high-tech company that specializes in artificial intelligence and…
Anew Labs is an AI drug discovery company that combines generative models with experimental science.
Yincheng Intelligent focuses on the research, application, innovation, and development of new productivity…
Simitech manufactures advanced MEMS pressure sensors for defense and aerospace.
Senmaru is a wafer-level passive device integrated device manufacturer (IDM).
HiDream.ai develops artificial intelligence models for text-to-image generation and image editing.
Yige Cloud is a zero-trust enterprise network security solution provider.
Yigen Technology,specializes in providing digital intellig ence solutions for the new energy sector
Zhaomo Vacuum is an enterprise integrating R&D, production, commissioning, and service of vacuum chambers.
QL Biopharma Funding FAQs
What does QL Biopharma do?
QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.
How much funding has QL Biopharma raised?
QL Biopharma has raised $44.7M across 1 round on record. The most recent is a Series C of $44.7M announced in Sep 2026.
When did QL Biopharma last raise funding?
QL Biopharma's most recent funding round on record is a Series C of $44.7M, announced in Sep 2026.
Who has invested in QL Biopharma?
Investors on record for QL Biopharma include Qiming Venture Partners, Tencent, Cathay Capital, 5Y Capital, Legend Star. FundedIQ records 21 investors in total.
Who is the CEO of QL Biopharma?
Andrew Leger is listed as CEO at QL Biopharma.
Where is QL Biopharma headquartered?
QL Biopharma is based in Changping, China.
How many employees does QL Biopharma have?
QL Biopharma is in the 51-100 employee band.
When was QL Biopharma founded?
QL Biopharma was founded in 2018.
About FundedIQ's QL Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for QL Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.